GlycoMimetics Inc
GLYC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.01B
Close$
$0.17
98.9% downside
Current Fair Value
98.9% downsideOvervalued by 98.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.01 Billion |
|---|---|
| Enterprise Value | $828.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-12818.01 |
| Beta | 1.6 |
| Outstanding Shares | 303,978,860 |
Return
| Return on Equity | -81.56% |
|---|---|
| Return on Assets | -75.30% |
| Return on Invested Capital | -120.30% |
Valuation & Multiples
| P/E Ratio | -3.87 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.73 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
February 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About GlycoMimetics Inc
CEO: Rachel King